This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
According to recent research published in the American Journal of Clinical Oncology - Cancer Clinical Trials, This phase I study was designed to determine the maximum tolerated dose (MTD) and preliminary efficacy of docetaxel with concurrent radiotherapy (RT), in high-risk squamous cell carcinoma of the head and neck.
We care about your feedback. Let us know how we can improve your CancerCompass experience.